Research ArticleMinireviews
Combretastatins: More Than Just Vascular Targeting Agents?
Lisa M. Greene, Mary J. Meegan and Daniela M. Zisterer
Journal of Pharmacology and Experimental Therapeutics November 2015, 355 (2) 212-227; DOI: https://doi.org/10.1124/jpet.115.226225
Lisa M. Greene
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute (L.M.G., D.M.Z.), and School of Pharmacy and Pharmaceutical Sciences, Centre for Synthesis and Chemical Biology (M.J.M.), Trinity College Dublin, Dublin, Ireland
Mary J. Meegan
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute (L.M.G., D.M.Z.), and School of Pharmacy and Pharmaceutical Sciences, Centre for Synthesis and Chemical Biology (M.J.M.), Trinity College Dublin, Dublin, Ireland
Daniela M. Zisterer
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute (L.M.G., D.M.Z.), and School of Pharmacy and Pharmaceutical Sciences, Centre for Synthesis and Chemical Biology (M.J.M.), Trinity College Dublin, Dublin, Ireland
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMinireviews
Combretastatins: More Than Just Vascular Targeting Agents?
Lisa M. Greene, Mary J. Meegan and Daniela M. Zisterer
Journal of Pharmacology and Experimental Therapeutics November 1, 2015, 355 (2) 212-227; DOI: https://doi.org/10.1124/jpet.115.226225
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement